<!--
# COPYRIGHT NOTICE
# This file is part of the "Universal Biomedical Skills" project.
# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
# All Rights Reserved.
#
# This code is proprietary and confidential.
# Unauthorized copying of this file, via any medium is strictly prohibited.
#
# Provenance: Authenticated by MD BABU MIA

-->

# Multi-Omics Integration Agent

**ID:** `biomedical.genomics.multi_omics_integration`
**Version:** 1.0.0
**Status:** Production
**Category:** Genomics / Multi-Omics / Data Integration

---

## Overview

The **Multi-Omics Integration Agent** orchestrates the integration of diverse omics data types (genomics, transcriptomics, epigenomics, proteomics, metabolomics) to provide holistic biological insights. Modern biomedical research increasingly relies on multi-omics approaches to understand complex biological systems, disease mechanisms, and treatment responses.

This agent leverages cutting-edge AI methodologies including graph neural networks, transformer-based cross-modal fusion, and explainable AI (XAI) to deliver clinically actionable multi-omics insights for precision medicine applications.

---

## Key Capabilities

### 1. Supported Omics Data Types

| Omics Layer | Data Type | Key Features |
|-------------|-----------|--------------|
| **Genomics** | WGS/WES, SNP arrays | SNVs, CNVs, SVs, germline/somatic |
| **Transcriptomics** | RNA-seq, scRNA-seq | Gene expression, splicing, fusion |
| **Epigenomics** | ATAC-seq, ChIP-seq, methylation | Chromatin accessibility, TF binding |
| **Proteomics** | Mass spec, RPPA | Protein abundance, PTMs |
| **Metabolomics** | LC-MS, NMR | Metabolite profiles, fluxes |
| **Spatial Omics** | Spatial transcriptomics | Tissue context, cell neighborhoods |

### 2. Integration Methods

| Method | Type | Best For | Output |
|--------|------|----------|--------|
| **MOFA+** | Factor analysis | Unsupervised integration | Latent factors |
| **CellOracle** | GRN + scATAC | Regulatory networks | TF-gene links |
| **totalVI** | Deep learning | scRNA + protein | Joint embeddings |
| **GLUE** | Graph-guided | Cross-modality | Cell matching |
| **MultiVI** | VAE-based | Multi-batch multi-modal | Harmonized data |
| **Seurat v5** | WNN | CITE-seq, multiome | Weighted neighbors |
| **ArchR** | Pipeline | scATAC + scRNA | Integrated analysis |

### 3. AI-Powered Analysis

| Technique | Application | Description |
|-----------|-------------|-------------|
| **Graph Neural Networks** | Biological networks | Model gene/protein interactions |
| **Transformers** | Cross-modal fusion | Attention-based multi-omics |
| **Autoencoders** | Dimensionality reduction | Joint latent spaces |
| **XAI (SHAP, LIME)** | Clinical decision support | Explainable predictions |

### 4. Clinical Applications

- **Precision oncology:** Multi-omics tumor profiling
- **Drug response:** Predict treatment outcomes
- **Biomarker discovery:** Multi-modal signatures
- **Patient stratification:** Subtype identification
- **Target prioritization:** Therapeutic target selection

---

## Usage

### Example Prompt

```text
Integrate multi-omics data from a lung cancer patient cohort for precision oncology analysis.

Available data:
- Whole exome sequencing (somatic mutations)
- RNA-seq (gene expression)
- ATAC-seq (chromatin accessibility)
- Proteomics (RPPA panel)
- Clinical outcomes (response to immunotherapy)

Tasks:
1. Integrate all omics layers using appropriate methods
2. Identify molecular subtypes
3. Find predictive biomarkers for immunotherapy response
4. Generate pathway-level insights
5. Provide explainable AI interpretations for clinical use
```

### Expected Output

```
## Multi-Omics Integration Analysis Report

### Cohort Summary
- **Patients:** 156 NSCLC patients
- **Data types:** WES, RNA-seq, ATAC-seq, RPPA
- **Outcome:** Immunotherapy response (CR/PR vs SD/PD)
- **Responders:** 62 (39.7%), Non-responders: 94 (60.3%)

### Integration Summary

#### Data Preprocessing
| Omics | Samples | Features | Missing |
|-------|---------|----------|---------|
| WES (mutations) | 156 | 18,234 genes | 0% |
| RNA-seq | 152 | 19,456 genes | 2.6% |
| ATAC-seq | 148 | 124,567 peaks | 5.1% |
| RPPA | 156 | 217 proteins | 0% |

#### Integration Method: MOFA+ with Graph Regularization

**Latent Factors Identified:** 15 factors explaining 78.3% variance

| Factor | Variance Explained | Top Omics | Biological Theme |
|--------|-------------------|-----------|------------------|
| F1 | 18.2% | RNA + Protein | Cell cycle / proliferation |
| F2 | 12.4% | ATAC + RNA | Immune infiltration |
| F3 | 9.8% | WES + RNA | DNA damage response |
| F4 | 8.1% | RNA + ATAC | EMT signature |
| F5 | 7.2% | Protein + RNA | Metabolic reprogramming |

### Molecular Subtype Identification

**4 Distinct Subtypes Identified:**

| Subtype | N | Characteristics | IO Response |
|---------|---|-----------------|-------------|
| **Immune-Hot** | 42 | High TILs, PD-L1+, IFN-γ signature | 71.4% |
| **Immune-Cold** | 38 | Low TILs, low MHC, EGFR mut | 15.8% |
| **Metabolic** | 41 | KRAS mut, metabolic reprogramming | 39.0% |
| **Proliferative** | 35 | High Ki67, cell cycle genes | 28.6% |

### Immunotherapy Response Biomarkers

#### Multi-Omics Predictive Signature (AUC = 0.87)

| Rank | Feature | Omics | Direction | SHAP Value |
|------|---------|-------|-----------|------------|
| 1 | TMB | WES | Higher → Response | 0.234 |
| 2 | CD8A expression | RNA | Higher → Response | 0.198 |
| 3 | PD-L1 protein | RPPA | Higher → Response | 0.187 |
| 4 | CXCL9 accessibility | ATAC | Open → Response | 0.156 |
| 5 | IFN-γ signature | RNA | Higher → Response | 0.142 |
| 6 | STK11 mutation | WES | Mutant → Resistance | -0.134 |
| 7 | KEAP1 mutation | WES | Mutant → Resistance | -0.128 |

#### Model Performance

| Metric | Single-Omics (RNA) | Multi-Omics |
|--------|-------------------|-------------|
| AUC | 0.74 | 0.87 |
| Accuracy | 68.2% | 81.4% |
| Sensitivity | 71.0% | 85.5% |
| Specificity | 66.0% | 78.7% |

### Pathway-Level Insights

#### Enriched Pathways in Responders

| Pathway | P-value | Omics Evidence |
|---------|---------|----------------|
| Antigen presentation | 1.2e-12 | RNA↑, ATAC open, Protein↑ |
| IFN-γ signaling | 3.4e-10 | RNA↑, ATAC open |
| T cell activation | 8.7e-9 | RNA↑, Protein↑ |
| PD-1/PD-L1 pathway | 2.1e-7 | RNA↑, Protein↑ |

#### Resistance Mechanisms (Non-Responders)

| Mechanism | Evidence | Actionable |
|-----------|----------|------------|
| STK11/KEAP1 co-mutation | WES, Cold TME | KRAS G12C inhibitors |
| Low MHC-I expression | RNA, ATAC closed | Epigenetic therapy |
| Metabolic reprogramming | RNA, Metabolomics | Metabolic modulators |
| β-catenin activation | WES, RNA | Wnt inhibitors |

### Explainable AI Clinical Report

**Patient Example: PT-089 (Non-responder)**

```
PREDICTION: Non-responder (Probability: 0.82)

KEY FACTORS:
1. STK11 frameshift mutation (chr19:1220321 c.del298G)
   - Impact: Loss of LKB1 tumor suppressor
   - Evidence: Cold tumor microenvironment

2. Low CD8A expression (z-score: -1.8)
   - T cell infiltration below cohort median

3. KEAP1 missense mutation (R320Q)
   - NRF2 pathway activation
   - Associated with immunotherapy resistance

RECOMMENDATION:
Consider combination therapy with KRAS G12C inhibitor
(if KRAS G12C positive) or metabolic modulators.
```
```

### LLM Agent Integration

```python
@tool
def integrate_multi_omics(
    omics_data: dict[str, str],
    method: str = "mofa",
    n_factors: int = 15,
    batch_correction: bool = True
) -> str:
    """
    Integrates multiple omics data types.

    Args:
        omics_data: Dict mapping omics type to file path
            e.g., {"rna": "expr.h5ad", "atac": "peaks.h5ad"}
        method: Integration method (mofa, totalvi, glue, multiVI)
        n_factors: Number of latent factors
        batch_correction: Apply batch correction

    Returns:
        Integrated analysis with latent factors and embeddings
    """
    pass


@tool
def identify_molecular_subtypes(
    integrated_data: str,
    n_clusters: int = None,
    method: str = "leiden"
) -> str:
    """
    Identifies molecular subtypes from integrated data.

    Args:
        integrated_data: Path to integrated multi-omics data
        n_clusters: Number of clusters (None = auto)
        method: Clustering method (leiden, kmeans, hierarchical)

    Returns:
        Subtype assignments with characterization
    """
    pass


@tool
def discover_multi_omics_biomarkers(
    integrated_data: str,
    outcome_column: str,
    method: str = "xgboost",
    explain: bool = True
) -> str:
    """
    Discovers predictive biomarkers across omics layers.

    Args:
        integrated_data: Path to integrated data
        outcome_column: Clinical outcome to predict
        method: ML method (xgboost, rf, elastic_net)
        explain: Generate SHAP explanations

    Returns:
        Ranked biomarkers with feature importance
    """
    pass


@tool
def generate_clinical_interpretation(
    patient_id: str,
    integrated_data: str,
    model_path: str
) -> str:
    """
    Generates explainable clinical interpretation for a patient.

    Args:
        patient_id: Patient identifier
        integrated_data: Path to integrated data
        model_path: Path to trained predictive model

    Returns:
        Explainable AI clinical report with recommendations
    """
    pass
```

---

## Prerequisites

### Required Packages

| Package | Version | Purpose |
|---------|---------|---------|
| **mofapy2** | >=0.7 | MOFA+ integration |
| **scvi-tools** | >=1.0 | totalVI, MultiVI |
| **scglue** | >=0.3 | Graph-guided integration |
| **scanpy** | >=1.9 | Single-cell analysis |
| **shap** | >=0.42 | Explainability |
| **xgboost** | >=2.0 | ML modeling |

### Dependencies

```
mofapy2>=0.7.0
scvi-tools>=1.0.0
scanpy>=1.9.0
anndata>=0.10.0
shap>=0.42.0
xgboost>=2.0.0
pandas>=2.0
numpy>=1.24
torch>=2.0
```

---

## Methodology

### Integration Pipeline

```
Raw Omics Data
├── Genomics (VCF)
├── Transcriptomics (counts)
├── Epigenomics (peaks)
└── Proteomics (intensities)
    ↓
Preprocessing & Normalization
├── Variant annotation
├── TPM/CPM normalization
├── Peak quantification
└── Protein normalization
    ↓
Feature Selection
├── High-variance genes
├── Variable peaks
└── Differential proteins
    ↓
Multi-Omics Integration
├── MOFA+ (factor analysis)
├── Graph methods (GLUE)
└── Deep learning (totalVI)
    ↓
Joint Analysis
├── Subtype discovery
├── Biomarker identification
└── Pathway enrichment
    ↓
Clinical Application
├── Predictive modeling
├── XAI interpretation
└── Treatment recommendation
```

### Integration Benchmarks

| Method | Scalability | Interpretability | Missing Data | Best For |
|--------|-------------|------------------|--------------|----------|
| MOFA+ | High | Factor weights | Handles well | Bulk omics |
| totalVI | Medium | Latent space | Moderate | CITE-seq |
| GLUE | Medium | Graph structure | Limited | Cross-modality |
| Seurat WNN | High | Weights | Limited | Multiome |

---

## Clinical Applications

### Precision Oncology
- Multi-omics tumor profiling
- Treatment response prediction
- Resistance mechanism discovery
- Biomarker-driven therapy selection

### Drug Development
- Target identification and validation
- Mechanism of action studies
- Patient stratification for trials
- Combination therapy rationale

### Rare Disease
- Variant-to-phenotype mapping
- Pathway-level diagnosis
- Novel disease gene discovery

---

## Related Skills

- **Single-Cell Foundation Models:** scRNA + scATAC integration
- **Pathway Analysis Agent:** Multi-omics pathway enrichment
- **Biomarker Discovery Agent:** Feature selection methods
- **Clinical Decision Support:** Treatment recommendations

---

## References

- **Argelaguet et al. (2020):** "MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data." *Genome Biology*
- **Gayoso et al. (2021):** "Joint probabilistic modeling of single-cell multi-omic data with totalVI." *Nature Methods*
- **Cao et al. (2022):** "Multi-omics single-cell data integration and regulatory inference with graph-linked unified embedding." *Nature Biotechnology*
- [AI-driven multi-omics integration](https://link.springer.com/article/10.1007/s10238-025-01965-9)

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu


<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->